TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Supply and Support of REBOA

Antihaemorrhagics
Balloon catheters
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: Leidos Supply: "Supply and Support of REBOA". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityLeidos SupplyScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: Leidos Supply
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for Leidos Supply. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
5.1Bids / Report
5.9% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 40 active published awards; 17 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityLeidos Supply
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published11 Nov 2022, 11:10 GMT
Last source update11 Nov 2022, 11:10 GMT
Recurring procurementNot published
ClassificationAntihaemorrhagics, Balloon catheters
Delivery area
UK
OCIDocds-h6vhtk-03837e
What is being bought
Leidos Supply Ltd intends to award a framework agreement to Prytime Medical Devices Inc for the supply and support of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA). This agreement will last for up to 3 years. Please note, this is NOT a request for companies to express interest.
What changed
From the official release history
  1. Status changed to complete
    11 Nov 2022, 11:10 GMT
  2. Official notice release published
    11 Nov 2022, 11:10 GMT
  3. Buyer information updated
    11 Nov 2022, 11:10 GMT
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    Status not published
    Published valueNot published
    Leidos Supply Ltd intends to award a framework agreement to Prytime Medical Devices Inc for the supply and support of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA). This agreement will last for up to 3 years with an estimated value of £272,000 - £680,000. It is considered that this contract can be placed using the negotiated procedure without prior publication of a contract notice pursuant to Article 32 (b)(ii) of Directive 2014/24/EC of the European parliament and of the council (regulation 32(2) (ii) of PCR 2015). Under regulation 32 (2)(b)(ii) of the Public Contract Regulations 2015 using the negotiated procedure without prior publication when competition is absent for technical reasons. Prytime Medical Devices Inc are the sole vendor to the UK for the main REBOA devices (catheter and catheter kit) required by the Ministry of Defence customer. If a company was selected that is not manufacturer approved then this could alter the performance characteristics of the devices, as well as potentially incurring significant medical malpractice claims.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    11 Nov 2022, 11:10 GMT
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 4 Nov 2022, 00:00 GMT · Not published
Commercial outcome and competition
Awards
Prytime Medical Devices Inc
Not published · Not published · active
Contracts
Contract
Not published · signed 4 Nov 2022, 00:00 GMT · active
Bid statistics
highestValidBidValue: 680000
lowestValidBidValue: 272000
highestValidBidValue: 680000 (lot 1)
lowestValidBidValue: 272000 (lot 1)
Buyer and organisations in this procedure

Leidos Supply

Contracting authority GB-FTS-144
View buyer profile

  • Leidos Supply
    buyer

    Monarch Court, 8 The Brooms, Emersons Green, Bristol, UK
    Samuel.Harrison@leidos.com

  • Leidos Supply Ltd
    reviewBody

    Bristol

  • Prytime Medical Devices Inc
    supplier

    Boerne, TX, US
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published
Planning and rationale
Planning budgetNot published
No-engagement rationaleNot published
Procedure rationalePlease explain in a clear and comprehensive manner why the award of the contract without prior publication in the Official Journal of the European Union is lawful, by stating the relevant facts and, as appropriate, the conclusions of law in accordance with the directive: (500 words maximum) Leidos Supply Ltd intends to award a framework agreement to Prytime Medical Devices Inc for the supply and support of Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA). This agreement will last for up to 3 years with an estimated value of £272,000 - £680,000. It is considered that this contract can be placed using the negotiated procedure without prior publication of a contract notice pursuant to Article 32 (b)(ii) of Directive 2014/24/EC of the European parliament and of the council (regulation 32(2) (ii) of PCR 2015). Under regulation 32 (2)(b)(ii) of the Public Contract Regulations 2015 using the negotiated procedure without prior publication when competition is absent for technical reasons. Prytime Medical Devices Inc are the sole vendor to the UK for the main REBOA devices (catheter and catheter kit) required by the Ministry of Defence customer. If a company was selected that is not manufacturer approved then this could alter the performance characteristics of the devices, as well as potentially incurring significant medical malpractice claims.